Alicia Morgans: Hi, and welcome to Clinical Case-Based Learning. We are here for a virtual tumor board in advanced prostate cancer. We’re going to start with case number one, Mr. John Roberts, who has a prostate cancer recurrence. Mr. Roberts is a 71-year-old man with a history of hypertension and locally advanced pT3N1M0 prostate adenocarcinoma. […]
Geoffrey Sonn: Welcome to case three of our Advanced Prostate Cancer Virtual Tumor Board. Present, Mr. David Garcia. This is a 79-year-old man with a history of arthritis, chronic lower back pain, and prostate cancer, diagnosed in 2008, based on an elevated PSA. His biopsy showed Gleason 3+4 prostate cancer, and he was treated with […]
Geoffrey Sonn: Welcome to the second case of our Clinical Case-Based Learning Virtual Tumor Board for Advanced Prostate Cancer. I’d like to introduce study two or patient two, Mr. Michael Miller, demonstrating a case of prostate cancer recurrence. This is a 69-year-old man with a history of coronary artery disease managed by two stents placed […]
(UroToday.com) The American Society for Radiation Oncology’s 2021 annual meeting included an educational session discussing multidisciplinary management of very high-risk prostate cancer and a presentation by Dr. Alicia Morgans highlighting systemic therapy for very high-risk to oligometastatic prostate cancer. Dr. Morgans started by highlighting the disease characteristics according to the NCCN guidelines for high and very-high […]
(UroToday.com) The American Society for Radiation Oncology’s 2021 annual meeting included an educational session discussing multidisciplinary management of very high-risk prostate cancer and a presentation by Dr. Ronald Chen highlighting radiation therapy for very high-risk to oligometastatic prostate cancer. Dr. Chen notes that among high-risk prostate cancer patients, two trials (NCIC PR.3 and SPCG-7) showed an […]
(UroToday.com) The Latin American sectional meeting at the 2021 American Society for Radiation Oncology annual meeting included a presentation by Dr. Christian Flores Balcazar discussing updates and controversies in the NCCN guidelines for radiation therapy and prostate cancer. Dr. Flores Balcazar started by highlighting that over the years the NCCN has become the market leader for […]
Some African American men are reluctant to have their prostate checked although they are at higher risk. But it’s critical. Had I not been getting my PSA checked since I was 40, I wouldn’t have caught the disease early enough and my quality of life could have suffered …or worse.
A primary endpoint analysis of the NRG Oncology Phase III clinical trial NRG-GU003 comparing hypofractionated post-operative prostate bed radiotherapy (HYPORT) to the conventional post-prostatectomy radiotherapy (COPORT) for men with prostate cancer determined that treatment with HYPORT yielded no increase in patient-reported genitourinary (GU) or gastrointestinal (GI) toxicity for trial participants. However, the trial failed to reject the […]
San Francisco, CA (UroToday.com) — A new study published in JCO Oncology Practice found that patients with certain cancers have a higher mortality risk than other cancer types if they have contracted the novel coronavirus (SARS-CoV-2). Specifically, older patients with B-cell malignancies who acquire SARS-CoV-2 who are undergoing cancer treatment are at increased risk of death compared to other […]
San Francisco, CA (UroToday.com) — In the NRG Oncology clinical trial NRG-RTOG 0815 comparing dose escalated radiotherapy (RT) in combination with short-term androgen suppression (ADT) to dose escalated RT alone for intermediate-risk prostate cancer patients, the addition of ADT did not improve overall survival results as hypothesized by researchers. These results were presented during the Plenary Session of […]
